Viridian Therapeutics, Inc.\DE (VRDN) Invested Capital (2013 - 2026)
Viridian Therapeutics, Inc.\DE (VRDN) recorded Invested Capital of $775.74 million in Q2 2026, up 44.7% from $535.96 million a year earlier and up 13.0% from the prior quarter.
Powered by 
Analysis
Viridian Therapeutics, Inc.\DE (VRDN) Invested Capital (2013 - 2026) Analysis & Trends
For FY2025, Viridian Therapeutics, Inc.\DE reported Invested Capital of $772.11 million, up 11.5% from FY2024.
- Annual Invested Capital has a five-year compound annual growth rate of 45.1% (FY2020 to FY2025).
- Across earlier years, Invested Capital came in at $692.22 million in FY2024 (+49.8%) and $462.23 million in FY2023.
- The Q2 2026 figure is the highest quarterly Invested Capital in data going back to Q4 2013.
- On a year-over-year basis, Invested Capital has increased for three consecutive quarters, with growth averaging 14.2% over the last six quarters.
- Per Business Quant, the preceding three quarters came in at $686.44 million (Q1 2026), $772.11 million (Q4 2025) and $523.86 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 88.79 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 134.01 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 64.89 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 95.89 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 79.44 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 50.26 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 68.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 38.08 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 148.69 Bn |
| 10 | Viridian Therapeutics, Inc.\DE | 2.20 Bn | 2.20 Bn | - | 775.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 775.74 Mn |
| Mar 31, 2026 | 686.44 Mn |
| Dec 31, 2025 | 772.11 Mn |
| Sep 30, 2025 | 523.86 Mn |
| Jun 30, 2025 | 535.96 Mn |
| Mar 31, 2025 | 625.16 Mn |
| Dec 31, 2024 | 692.22 Mn |
| Sep 30, 2024 | 728.02 Mn |
| Jun 30, 2024 | 549.79 Mn |
| Dec 31, 2023 | 462.23 Mn |
| Dec 31, 2020 | 120.04 Mn |
| Sep 30, 2020 | 29.88 Mn |
| Jun 30, 2020 | 29.97 Mn |
| Mar 31, 2020 | 34.37 Mn |
| Dec 31, 2019 | 24.06 Mn |
| Sep 30, 2019 | 32.40 Mn |
| Jun 30, 2019 | 43.59 Mn |
| Mar 31, 2019 | 51.35 Mn |
| Dec 31, 2018 | 61.64 Mn |
| Sep 30, 2018 | 70.92 Mn |
API Access
Viridian Therapeutics, Inc.\DE Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=VRDN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "VRDN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=VRDN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();